| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |